BioGenomica S.A., a biotechnology company founded in 2004, provides a wide range of highly specialized services in genetic testing. The services include molecular analysis of disease predisposing genes with applications in Oncology (sporadicand hereditary cancer), Cardiovascular and Neurological Disorders, ObGYN (Obstetrics and Gynaecology) and Assisted Reproduction.
Technologies / Services offered or sought
BioGenomica S.A. provides cytogenetic and molecular cytogenetic analyses as well, with applications mainly in Oncology and Hematology.
All the tests are carried out in-house, in BioGenomica's state-of-the-art laboratories.
The European Molecular Genetics Quality Network (EMQN) evaluates annually the quality of the services for the majority of the genetic tests provided.
Technology and R&D
BioGenomica strives for scientific excellence. It is a subsidiary of Biomedica Life Sciences S.A., one of the leading companies of Greece in the fields of radiopharmaceuticals and imaging instrumentation.
BioGenomica S.A. participates in clinical studies and protocols as the Reference Laboratory for custom-designed genetic tests. BioGenomica is a partner in funded European (FP6 and FP7) Research Programs aiming towards the development of novel label-free biosensors for direct applications in mutation detection devices.
In the research front, BioGenomica S.A. has an important role in collaborative, large-scale population genetic studies aiming at identifying and characterizing new disease predisposing genetic alterations as well in genetic profiling for the development of novel diagnostic tests.